Home/Filings/4/0000905718-19-000757
4//SEC Filing

TOTH ROBERT JOSEPH JR 4

Accession 0000905718-19-000757

CIK 0001498382other

Filed

Sep 8, 8:00 PM ET

Accepted

Sep 9, 4:31 PM ET

Size

7.8 KB

Accession

0000905718-19-000757

Insider Transaction Report

Form 4
Period: 2019-09-05
Transactions
  • Award

    Options (Right to Buy)

    2019-09-05+39,56739,567 total
    Exercise: $0.61Exp: 2029-09-05Common Stock (39,567 underlying)
  • Award

    Options (Right to Buy)

    2019-09-05+35,43335,433 total
    Exercise: $0.61Exp: 2029-09-05Common Stock (35,433 underlying)
Footnotes (2)
  • [F1]Subject to stockholder approval of the increase in the number of shares authorized for issuance under the DelMar Pharmaceuticals, Inc. 2017 Omnibus Equity Incentive Plan, as amended, at the next annual meeting, the shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019.
  • [F2]The shares subject to the option vest in twelve (12) equal monthly installments beginning on October 5, 2019.

Issuer

DelMar Pharmaceuticals, Inc.

CIK 0001498382

Entity typeother

Related Parties

1
  • filerCIK 0001585020

Filing Metadata

Form type
4
Filed
Sep 8, 8:00 PM ET
Accepted
Sep 9, 4:31 PM ET
Size
7.8 KB